Life ScienceCompany
Gossamer Bio - Clinical Stage Integrin Activator Program Ownership
Who owns Gossamer Bio - Clinical Stage Integrin Activator Program?
Gossamer Bio - Clinical Stage Integrin Activator Program is owned by 149 Bio. It was acquired on February 23, 2023.
Gossamer Bio - Clinical Stage Integrin Activator Program Business Overview
Where is Gossamer Bio - Clinical Stage Integrin Activator Program headquartered?
Gossamer Bio - Clinical Stage Integrin Activator Program is headquartered in San Diego, California.
What sector is Gossamer Bio - Clinical Stage Integrin Activator Program in?
Gossamer Bio - Clinical Stage Integrin Activator Program is a life science company.
Life Science M&A Summary in 2023
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.
Join Mergr to view all 191 acquisitions of life science companies in 2023, including 18 acquisitions by private equity firms, and 173 by strategics.